<DOC>
	<DOC>NCT00616421</DOC>
	<brief_summary>To evaluate the safety and immune response of Novartis MenACWY conjugate vaccine when given to healthy children compared to a licensed Meningococcal ACWY polysaccharide-protein conjugate vaccine.</brief_summary>
	<brief_title>Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<criteria>healthy 210 years of age children, inclusive and for whom, after the nature of the study has been explained, the parent or legal guardian has provided written informed consent who are available for all visits and telephone calls scheduled for the study who are uptodate with ageappropriate routine childhood vaccinations whose parent or legal guardian is unwilling or unable to give written informed consent who had a previous or suspected disease caused by N. meningitidis; who have previously been immunized with a meningococcal vaccine or vaccine containing meningococcal antigen(s) who have received any investigational agents or vaccines within 90 days prior to enrollment who have any serious acute, chronic or progressive disease who have epilepsy or any progressive neurological disease or history of Guillain Barr√© Syndrome who have a history of anaphylaxis, serious vaccine reactions who have a known or suspected impairment/alteration of immune function, either congenital or acquired or resulting from who are known to have a bleeding diathesis, or any condition that may be associated with a prolonged bleeding time who have Down's syndrome or other known cytogenic disorders</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>vaccine</keyword>
	<keyword>children</keyword>
	<keyword>healthy</keyword>
	<keyword>meningitis</keyword>
	<keyword>meningococcal</keyword>
	<keyword>prevention of meningococcal disease serogroups ACWY</keyword>
	<keyword>Menveo</keyword>
</DOC>